AKT1 and endometrial cancer: Interestingly activation of epidermal growth factor receptor (EGFR)/insulin-like growth factor 1 receptor(IGFR-1)/AKT signalling, a pathway previously shown to be associated with elevated SRPK1 expression, promoted resistance to SRPK1 inhibition, suggesting a potential feedback loop mechanism in endometrial cancer cells [31].